Isolagen News (AMEX:ILE)
| Latest Isolagen News Headlines | | Date | Time | Source | | | 04/25/2008 | 2:00PM | PRNUS | Isolagen to Present at the Morgan Stanley Global Healthcare Unplugged Conference
EXTON, Pa., April 25 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced that the Company will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 at 3:40 p.m. EDT. The conference is being held April 30 - May 2, 2008 at the Ritz-Carlton Key Biscayne... More...>> |
| 03/24/2008 | 8:30AM | PRNUS | Isolagen, Inc. Sells Switzerland Facility
EXTON, Pa., March 24 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced the sale of its facility located in Switzerland for approximately $6.4 million, net. $5.85 million of the sale amount was paid at the time of closing and the remaining proceeds are expected within the next six weeks.
"This... More...>> |
| 03/14/2008 | 7:30AM | PRNUS | Isolagen, Inc. Promotes Todd Greenspan to Chief Financial Officer (CFO)
John Maslowski Named Vice President, Operations
EXTON, Pa., March 14 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced that the Company's Vice President and Corporate Controller, Todd Greenspan, has been promoted to Chief Financial Officer (CFO) and John Maslowski has been promoted to Vice President... More...>> |
| 03/13/2008 | 5:15PM | PRNUS | Isolagen, Inc. Receives Notification Letter from American Stock Exchange
EXTON, Pa., March 13 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced that on March 12, 2008 it received notice from the American Stock Exchange (AMEX) advising the Company that it does not meet certain of the continued listing standards as set forth in Part 10 of the AMEX Company Guide.
AMEX... More...>> |
| 01/15/2008 | 9:15AM | PRNUS | Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
- Study Subjects Now In Follow-up Period -
EXTON, Pa., Jan. 15 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) announced today that injections have been completed in the pivotal Phase III multi-center, double-blind, randomized, placebo-controlled clinical trials evaluating the Isolagen Therapy(TM) for the treatment... More...>> |
| 01/09/2008 | 9:53AM | PRNUS | Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
EXTON, Pa., Jan. 8 /PRNewswire/ -- Isolagen(TM), Inc. (AMEX:ILE) announced today that Nicholas L. Teti, Jr., Chairman, and Declan Daly, Chief Executive Officer of Isolagen, will present at the 26th Annual JPMorgan Healthcare Conference on Thursday, January 10, 2008 at 2:00 p.m. (Pacific Time) / 5:00 p.m. (Eastern Time... More...>> |
| 01/08/2008 | 8:45AM | PRNUS | Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
EXTON, Pa., Jan. 8 /PRNewswire/ -- Isolagen(TM), Inc. (AMEX:ILE) announced today that Nicholas L. Teti, Jr., Chairman, and Declan Daly, Chief Executive Officer of Isolagen, will present at the 26th Annual JPMorgan Healthcare Conference on Thursday, January 10, 2008 at 2:00 p.m. (Pacific Time) / 11:00 a.m. (Eastern Time... More...>> |
| 01/08/2008 | 8:30AM | PRNUS | Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
Nicholas L. Teti, Jr. will continue as Chairman of the Board
EXTON, Pa., Jan. 8 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) announced today that the Board of Directors has named Declan Daly as Chief Executive Officer (CEO) of the Company. Mr. Daly will continue as Chief Financial Officer (CFO) of Isolagen... More...>> |
| 11/27/2007 | 4:15PM | PRNUS | Isolagen Modifies Ongoing Clinical Program for Acne Scars
- FDA Recommends Further Analysis of Evaluator Assessment Scale and Photo Guide; Company Proposes Amending Previously Announced Phase III Study as a Phase II/III Study -
EXTON, Pa., Nov. 27 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) announced today that the Food and Drug Administration (FDA) has provided... More...>> |
| 11/07/2007 | 2:22PM | PRNUS | Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
EXTON, Pa., Nov. 7 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) announces the initiation of a Phase III clinical program to investigate Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. Isolagen also has a pivotal Phase III clinical program underway to evaluate the Isolagen Therapy... More...>> |
| 11/05/2007 | 4:00PM | PRNUS | Isolagen, Inc. Reports Results of Shareholders Annual Meeting
Dr. Kenneth A. Selzer Joins Company's Board of Directors
EXTON, Pa., Nov. 5 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced the results of its 2007 Annual Meeting of Stockholders, held today in Exton, Pennsylvania.
Stockholders elected Dr. Kenneth A. Selzer to serve as a new Director. Dr. Selzer... More...>> |
| 10/30/2007 | 9:00AM | PRNUS | Isolagen to Present at the 2007 CIBC World Markets 18th Annual Healthcare Conference
EXTON, Pa., Oct. 30 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced that Nicholas L. Teti, Jr., Isolagen Chairman and Chief Executive Officer, will present at the 2007 CIBC World Markets 18th Annual Healthcare Conference on November 6, 2007 at 8:35 a.m. EST. The conference will be held at the... More...>> |
| 09/24/2007 | 5:00PM | PRNUS | Isolagen, Inc. Postpones Annual Meeting
EXTON, Pa., Sept. 24 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) announced today that it is postponing its 2007 Annual Meeting of Stockholders scheduled for tomorrow in Nashville, Tennessee in order to obtain a quorum of shareholder votes. The company has rescheduled the annual meeting for Monday, November... More...>> |
| 09/05/2007 | 9:00AM | PRNUS | Isolagen, Inc. to Present at the First Albany Capital Regenerative Technologies Conference
EXTON, Pa., Sept. 5 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced that Nicholas L. Teti, Jr., Isolagen Chairman and Chief Executive Officer, will present at the First Albany Capital Regenerative Technologies Conference on Tuesday, September 11, 2007 at 10:20 a.m. ET. The conference will be... More...>> |
| 08/23/2007 | 9:00AM | PRNUS | Isolagen Inc. Completes Registered Direct Offering of Common Stock
EXTON, Pa., Aug. 23 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced that it completed its previously announced registered direct offering of approximately 6.76 million shares of common stock at a price of $2.04 per share to institutional investors for gross proceeds of approximately $13.8 million... More...>> |
| 08/15/2007 | 9:15AM | PRNUS | Isolagen, Inc. to Raise Approximately $14 Million in Registered Direct Offering of Common Stock
-Company Withdraws Registration Statements for Proposed Exchange and New Convertible Note Offerings-
EXTON, Pa., Aug. 15 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (AMEX:ILE) today announced it has obtained commitments to purchase shares of its common stock in a registered direct offering for gross proceeds of $13.8... More...>> |
| 07/11/2007 | 8:00AM | PRNUS | Isolagen Files Registration Statements for Proposed Exchange and New Convertible Note Offerings
EXTON, Pa., July 11 /PRNewswire-FirstCall/ -- Isolagen, Inc. (AMEX:ILE) today announced that it has filed registration statements with the Securities and Exchange Commission (SEC) relating to a proposed exchange offer involving holders of its currently outstanding 3.5% Subordinated Convertible notes due 2024 and a proposed... More...>> |
| 07/06/2007 | 8:30AM | PRNUS | Isolagen, Inc. Promotes Declan Daly to Chief Operating Officer
EXTON, Pa., July 6 /PRNewswire-FirstCall/ -- Isolagen, Inc. (AMEX:ILE) today announced that the Company's Chief Financial Officer (CFO), Declan Daly, has been appointed to the position of Chief Operating Officer. In addition to his current responsibilities as CFO, Mr. Daly will oversee Manufacturing Operations, Clinical... More...>> |
| 03/09/2007 | 8:00AM | PRNUS | Isolagen to Present at the Cowen and Company 27th Annual Health Care Conference
EXTON, Pa., March 9 /PRNewswire-FirstCall/ -- Isolagen, Inc. (AMEX:ILE) today announced that it has been invited to present at the Cowen and Company 27th Annual Health Care Conference on Thursday, March 15, 2007 at 10:15 a.m. EST. The conference will be held at the Boston Marriott Copley Place Hotel. The presentation... More...>> |
| 02/14/2007 | 9:00AM | PRNUS | Isolagen to Present at the Roth Capital Partners 19th Annual OC Conference
EXTON, Pa., Feb. 14 /PRNewswire-FirstCall/ -- Isolagen, Inc. (AMEX:ILE) today announced that it has been invited to present at the 19th Annual Roth Capital Partners OC Conference on Wednesday, February 21, 2007 at 8:30 a.m. PST at the Ritz-Carlton Laguna Niguel in Dana Point, California. The presentation will be webcast... More...>> |
|
|
|